Results 11 to 20 of about 8,151 (283)

Guidelines on the use of extracorporeal photopheresis [PDF]

, 2013
Peer ...
Arenberger, P., Assaf, C., Bagot, M., Barr, M., Berlin, G., Bohbot, A., Bruckner-Tuderman, L., Calzavara-Pinton, P., Dreno, B., Enk, A., French, L., Gniadecki, R., Gollnick, H., Greinix, H., Hertl, M., Hillen, U., Jaksch, P., Jantschitsch, C., Jung, A., Just, U., Klemke, C. -D., Knobler, R., Laroche, L., Lippert, U., Ludvigsson, J., Luger, T., Papadavid, E., Pehamberger, H., Quaglino, P., Ranki, A., Reinisch, W., Scarisbrick, J., Schwarz, T., Stadler, R., Sterry, W., Wolf, I. H., Wolf, P., Worm, M., Zic, J., Zouboulis, C. C.   +39 more
core   +3 more sources

Extracorporeal Photopheresis Enhances the Frequency and Function of Highly Suppressive FoxP3 + Treg Subsets in Heart Transplanted Individuals. [PDF]

Transplantation
Background. Extracorporeal photopheresis (ECP) has emerged as a prophylactic and therapeutic immunomodulatory option for managing acute rejection in heart transplants (HTx).
Mottola M, Bruzzaniti S, Piemonte E, Lepore MT, Petraio A, Romano R, Castiglione A, Izzo L, Perna F, De Falco C, Brighel F, Formisano L, Gravina MT, Marino M, De Feo M, Matarese G, Galgani M.   +16 more
europepmc   +2 more sources

Is a Functional Cure Possible in Autoimmune Diseases? Evidence from Trigger Eradication, Transplantation, and Cellular Therapies [PDF]

Rheumatology and Therapy
Introduction Traditionally considered incurable, autoimmune diseases (AIDs) may—in specific circumstances—achieve sustained remission or even a “functional cure,” defined as durable clinical and laboratory remission without immunosuppression. This review
Jozélio Freire de Carvalho, Carlos Ewerton Maia Rodrigues   +1 more
doaj   +2 more sources

Extracorporeal Photopheresis—An Overview

Frontiers in Medicine, 2018
Extracorporeal photopheresis (ECP) has been in clinical use for over three decades after receiving FDA approval for the palliative treatment of the Sézary Syndrome variant of cutaneous T-cell lymphoma (CTCL) in 1988.
Ara Cho, Christian Jantschitsch, Robert Knobler   +2 more
doaj   +3 more sources

Extracorporeal photopheresis as a therapeutic approach for treatment resistant immune-related adverse events in anti-PD-1-treated melanoma patients [PDF]

Frontiers in Immunology
BackgroundCheckpoint inhibition induced immune-related adverse events (irAE) may be steroid-dependent or steroid-refractory and are associated with increased morbidity, mortality and potentially compromised anti-tumor immunity.
Carl Maximilian Thielmann, Carl Maximilian Thielmann, Johanna Andrea Seier, Lisa Schielke, Lea Jessica Albrecht, Lisa Zimmer, Elisabeth Livingstone, Anne Zaremba, Anne Zaremba, Georg Lodde, Georg Lodde, Joachim Dissemond, Wiebke Sondermann, Frederik Krefting, Alpaslan Tasdogan, Alexander Roesch, Eva Hadaschik, Florian Rambow, Klaus Griewank, Selma Ugurel, Dirk Schadendorf, Dirk Schadendorf, Dirk Schadendorf, Jan-Malte Placke   +23 more
doaj   +2 more sources

Clinical Results of Extracorporeal Photopheresis [PDF]

Transfusion Medicine and Hemotherapy, 2012
Extracorporeal photopheresis (ECP) is a combination of leukapheresis and photodynamic therapy in which blood is treated with photoactivable drugs which are then activated with ultraviolet light and re-infused to the patient. It has been used successfully for more than 30 years in the treatment of erythrodermic cutaneous T-cell lymphoma (CTCL) and over ...
Nina Worel, Gerda Leitner
openalex   +3 more sources

Extracorporeal photopheresis as induction therapy in lung transplantation for cystic fibrosis: a pilot randomized trial [PDF]

Frontiers in Immunology
IntroductionExtracorporeal photopheresis (ECP) is a viable treatment that slows the progression of chronic lung allograft dysfunction. Despite its immunoregulatory potential, data on extracorporeal photopheresis as an induction therapy remain rather ...
Ilaria Righi, Claudio Fenizia, Daria Trabattoni, Mario Nosotti, Mario Nosotti, Giacomo Grisorio, Claudia Vanetti, Claudia Vanetti, Sonia di Tella, Cristina Mocellin, Norma Fantini, Daniele Prati, Letizia Corinna Morlacchi, Valeria Rossetti, Francesco Blasi, Francesco Blasi, Mario Clerici, Mario Clerici, Lorenzo Paolo Rosso, Lorenzo Paolo Rosso   +19 more
doaj   +2 more sources

Extracorporeal Photopheresis: Secreted Factors That Promote Immunomodulation

Transplantation Direct
Extracorporeal photopheresis (ECP) is a therapy indicated for various T cell–mediated conditions, including cutaneous T-cell lymphoma (CTCL), graft-versus-host disease (GVHD), and solid organ transplant rejection.
Jorge H. Garcia-Almeida, L. Heger, Holger Hackstein   +2 more
semanticscholar   +2 more sources

Use of Extracorporeal Photopheresis Treatment Over Time (2001–2023) in Alberta, Canada: A Retrospective Cohort Study [PDF]

Health Science Reports
Louis Girard, Sylvia Aponte‐Hao, Jason R. Randall, Karen J. B. Martins, Huong Luu, Khanh Vu, Tyler Williamson, Scott W. Klarenbach   +7 more
doaj   +2 more sources

The Role of Extracorporeal Photopheresis in the Management of Graft Versus Host Disease: Narrative Review

ImmunoTargets and Therapy
Ayenew Berhan, Shewaneh Damtie, Andargachew Almaw, Biruk Legesse, Bekele Sharew, Birhanu Getie, Mulat Erkihun, Yenealem Solomon Department of Medical Laboratory Science, College of Health Science, Debre Tabor University, Debre Tabor ...
Berhan A, Damtie S, Almaw A, Legesse B, Sharew B, Getie B, Erkihun M, Solomon Y   +7 more
doaj   +2 more sources